RC108 / Rongchang Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RC108 / Rongchang Pharma
NCT04617314: A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Recruiting
1
32
RoW
RC108, RC108 for injection
RemeGen Co., Ltd.
Solid Tumor
05/25
12/25

Download Options